Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Alpha Galactosidase A market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Alpha Galactosidase Amarket, defines the market attractiveness level of Alpha Galactosidase A market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Alpha Galactosidase A industry, describes the types of Alpha Galactosidase A market, the applications of major players and the market size, and deeply analyzes the current situation of the global Alpha Galactosidase A market and the development prospects and opportunities of Alpha Galactosidase A industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Alpha Galactosidase A market in Chapter 13.
By Player:
Protalix BioTherapeutics, Inc
Pharming Group NV
Amicus Therapeutics, Inc
Greenovation Biotech GmbH
JCR Pharmaceuticals Co, Ltd
Shire Plc
iBio, Inc
ISU ABXIS Co,Ltd
By Type:
Agalsidase Alfa
AVRRD-01
Migalastat Hydrochloride
MOSS-AGAL
Others
By End-User:
Hospital
Clinic
Home Care
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Alpha Galactosidase A Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Alpha Galactosidase A Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Alpha Galactosidase A Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Alpha Galactosidase A Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Alpha Galactosidase A Market Analysis and Outlook to 2022
-
7.1 Global Alpha Galactosidase A Consumption (2017-2022)
-
7.2 United States Alpha Galactosidase A Consumption (2017-2022)
-
7.3 Europe Alpha Galactosidase A Consumption (2017-2022)
-
7.4 China Alpha Galactosidase A Consumption (2017-2022)
-
7.5 Japan Alpha Galactosidase A Consumption (2017-2022)
-
7.6 India Alpha Galactosidase A Consumption (2017-2022)
-
7.7 South Korea Alpha Galactosidase A Consumption (2017-2022)
8 Region and Country-wise Alpha Galactosidase A Market Analysis and Outlook to 2028
-
8.1 Global Alpha Galactosidase A Consumption Forecast (2022-2028)
-
8.2 United States Alpha Galactosidase A Consumption Forecast (2022-2028)
-
8.3 Europe Alpha Galactosidase A Consumption Forecast (2022-2028)
-
8.4 China Alpha Galactosidase A Consumption Forecast (2022-2028)
-
8.5 Japan Alpha Galactosidase A Consumption Forecast (2022-2028)
-
8.6 India Alpha Galactosidase A Consumption Forecast (2022-2028)
-
8.7 South Korea Alpha Galactosidase A Consumption Forecast (2022-2028)
9 Global Alpha Galactosidase A Market Outlook by Types and Applications to 2022
-
9.1 Global Alpha Galactosidase A Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Agalsidase Alfa Consumption and Growth Rate (2017-2022)
-
9.1.2 Global AVRRD-01 Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Migalastat Hydrochloride Consumption and Growth Rate (2017-2022)
-
9.1.4 Global MOSS-AGAL Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Alpha Galactosidase A Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Home Care Consumption and Growth Rate (2017-2022)
10 Global Alpha Galactosidase A Market Outlook by Types and Applications to 2028
-
10.1 Global Alpha Galactosidase A Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Agalsidase Alfa Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global AVRRD-01 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Migalastat Hydrochloride Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global MOSS-AGAL Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Alpha Galactosidase A Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Home Care Consumption Forecast and Growth Rate (2022-2028)
11 Global Alpha Galactosidase A Import and Export Analysis (Top 5 Countries)
-
11.1 Global Alpha Galactosidase A Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Alpha Galactosidase A Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Alpha Galactosidase A Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Alpha Galactosidase A Market Competitive Analysis
-
14.1 Protalix BioTherapeutics, Inc
-
14.1.1 Protalix BioTherapeutics, Inc Company Details
-
14.1.2 Protalix BioTherapeutics, Inc Alpha Galactosidase A Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Protalix BioTherapeutics, Inc Alpha Galactosidase A Product and Service
-
14.2 Pharming Group NV
-
14.2.1 Pharming Group NV Company Details
-
14.2.2 Pharming Group NV Alpha Galactosidase A Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Pharming Group NV Alpha Galactosidase A Product and Service
-
14.3 Amicus Therapeutics, Inc
-
14.3.1 Amicus Therapeutics, Inc Company Details
-
14.3.2 Amicus Therapeutics, Inc Alpha Galactosidase A Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Amicus Therapeutics, Inc Alpha Galactosidase A Product and Service
-
14.4 Greenovation Biotech GmbH
-
14.4.1 Greenovation Biotech GmbH Company Details
-
14.4.2 Greenovation Biotech GmbH Alpha Galactosidase A Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Greenovation Biotech GmbH Alpha Galactosidase A Product and Service
-
14.5 JCR Pharmaceuticals Co, Ltd
-
14.5.1 JCR Pharmaceuticals Co, Ltd Company Details
-
14.5.2 JCR Pharmaceuticals Co, Ltd Alpha Galactosidase A Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 JCR Pharmaceuticals Co, Ltd Alpha Galactosidase A Product and Service
-
14.6 Shire Plc
-
14.6.1 Shire Plc Company Details
-
14.6.2 Shire Plc Alpha Galactosidase A Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Shire Plc Alpha Galactosidase A Product and Service
-
14.7 iBio, Inc
-
14.7.1 iBio, Inc Company Details
-
14.7.2 iBio, Inc Alpha Galactosidase A Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 iBio, Inc Alpha Galactosidase A Product and Service
-
14.8 ISU ABXIS Co,Ltd
-
14.8.1 ISU ABXIS Co,Ltd Company Details
-
14.8.2 ISU ABXIS Co,Ltd Alpha Galactosidase A Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 ISU ABXIS Co,Ltd Alpha Galactosidase A Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Alpha Galactosidase A
-
Figure Alpha Galactosidase A Picture
-
Table Global Alpha Galactosidase A Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Alpha Galactosidase A Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Alpha Galactosidase A Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Alpha Galactosidase A Consumption by Country (2017-2022)
-
Figure United States Alpha Galactosidase A Consumption and Growth Rate (2017-2022)
-
Table Europe Alpha Galactosidase A Consumption and Growth Rate (2017-2022)
-
Figure China Alpha Galactosidase A Consumption and Growth Rate (2017-2022)
-
Figure Japan Alpha Galactosidase A Consumption and Growth Rate (2017-2022)
-
Figure India Alpha Galactosidase A Consumption and Growth Rate (2017-2022)
-
Figure South Korea Alpha Galactosidase A Consumption and Growth Rate (2017-2022)
-
Figure Global Alpha Galactosidase A Consumption Forecast by Country (2022-2028)
-
Figure United States Alpha Galactosidase A Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Alpha Galactosidase A Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Alpha Galactosidase A Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Alpha Galactosidase A Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Alpha Galactosidase A Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Alpha Galactosidase A Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Agalsidase Alfa Consumption and Growth Rate (2017-2022)
-
Figure Global AVRRD-01 Consumption and Growth Rate (2017-2022)
-
Figure Global Migalastat Hydrochloride Consumption and Growth Rate (2017-2022)
-
Figure Global MOSS-AGAL Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Home Care Consumption and Growth Rate (2017-2022)
-
Figure Global Agalsidase Alfa Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global AVRRD-01 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Migalastat Hydrochloride Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global MOSS-AGAL Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Home Care Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Alpha Galactosidase A Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Alpha Galactosidase A Export by Region (Top 5 Countries) (2017-2028)
-
Table Protalix BioTherapeutics, Inc (Foundation Year, Company Profile and etc.)
-
Table Protalix BioTherapeutics, Inc Alpha Galactosidase A Sales, Price, Value and Gross Profit (2017-2022)
-
Table Protalix BioTherapeutics, Inc Alpha Galactosidase A Product and Service
-
Table Pharming Group NV (Foundation Year, Company Profile and etc.)
-
Table Pharming Group NV Alpha Galactosidase A Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pharming Group NV Alpha Galactosidase A Product and Service
-
Table Amicus Therapeutics, Inc (Foundation Year, Company Profile and etc.)
-
Table Amicus Therapeutics, Inc Alpha Galactosidase A Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amicus Therapeutics, Inc Alpha Galactosidase A Product and Service
-
Table Greenovation Biotech GmbH (Foundation Year, Company Profile and etc.)
-
Table Greenovation Biotech GmbH Alpha Galactosidase A Sales, Price, Value and Gross Profit (2017-2022)
-
Table Greenovation Biotech GmbH Alpha Galactosidase A Product and Service
-
Table JCR Pharmaceuticals Co, Ltd (Foundation Year, Company Profile and etc.)
-
Table JCR Pharmaceuticals Co, Ltd Alpha Galactosidase A Sales, Price, Value and Gross Profit (2017-2022)
-
Table JCR Pharmaceuticals Co, Ltd Alpha Galactosidase A Product and Service
-
Table Shire Plc (Foundation Year, Company Profile and etc.)
-
Table Shire Plc Alpha Galactosidase A Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shire Plc Alpha Galactosidase A Product and Service
-
Table iBio, Inc (Foundation Year, Company Profile and etc.)
-
Table iBio, Inc Alpha Galactosidase A Sales, Price, Value and Gross Profit (2017-2022)
-
Table iBio, Inc Alpha Galactosidase A Product and Service
-
Table ISU ABXIS Co,Ltd (Foundation Year, Company Profile and etc.)
-
Table ISU ABXIS Co,Ltd Alpha Galactosidase A Sales, Price, Value and Gross Profit (2017-2022)
-
Table ISU ABXIS Co,Ltd Alpha Galactosidase A Product and Service
-
